NOVOZYMES AS/FI - ADR (NVZMY)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / ADR
Symbol
NVZMY
Price per share
$63.62
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
30,022
Total reported value
$1,836,504
% of total 13F portfolios
0%
Share change
+588
Value change
+$27,941
Number of holders
9
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, NOVOZYMES AS/FI - ADR (NVZMY) has 9 institutional shareholders filing 13F forms. They hold 30,022 shares. .

Institutional Holders of NOVOZYMES AS/FI - ADR (NVZMY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 2,275 $144,736 -$8,016 $63.62 1
2025 Q3 30,022 $1,836,504 +$27,941 $61.13 9
2025 Q2 29,683 $2,123,231 +$254,859 $71.63 11
2025 Q1 26,118 $1,521,281 +$69,773 $58.41 8
2024 Q4 24,920 $1,408,997 -$351,199 $56.54 8
2024 Q3 29,977 $2,160,295 -$257,554 $72.01 9
2024 Q2 26,287 $1,605,810 -$8,782 $61.07 6
2024 Q1 26,515 $1,555,418 -$2,785,478 $58.86 9
2023 Q4 77,968 $4,279,330 -$1,158,082 $54.90 10
2023 Q3 97,575 $3,927,558 +$49,620 $40.21 8
2023 Q2 96,342 $4,484,993 -$157,577 $46.56 6
2023 Q1 94,313 $4,820,276 +$783,402 $51.16 5
2022 Q4 88,980 $4,490,578 +$260,699 $50.46 7
2022 Q3 83,808 $4,254,000 -$42,706 $50.88 6
2022 Q2 84,324 $5,058,000 +$296,867 $60.00 7
2022 Q1 78,802 $5,420,000 -$7,735 $69.28 9
2021 Q4 78,908 $6,539,000 +$360,537 $82.64 8
2021 Q3 75,027 $5,135,000 -$583,784 $68.49 9
2021 Q2 82,720 $6,237,452 -$17,511,742 $75.34 13
2021 Q1 356,030 $22,850,385 +$692,908 $64.18 13
2020 Q4 348,396 $19,890,345 -$88,800,700 $57.14 15
2020 Q3 1,740,745 $109,595,000 +$86,146,105 $62.94 15
2020 Q2 356,764 $20,628,000 -$3,994,103 $57.80 15
2020 Q1 414,164 $18,838,000 +$424,585 $45.49 16
2019 Q4 385,163 $18,805,000 -$5,449,255 $48.83 16
2019 Q3 514,873 $21,650,000 -$1,016,599 $42.05 17
2019 Q2 539,069 $25,093,000 +$650,122 $46.53 16
2019 Q1 525,217 $24,167,000 +$373,679 $46.02 15
2018 Q4 517,055 $23,123,000 -$2,462,693 $44.74 15
2018 Q3 572,054 $31,322,000 +$2,562,742 $54.75 14
2018 Q2 525,246 $26,501,000 -$2,538,660 $50.43 13
2018 Q1 575,340 $30,081,000 +$3,548,728 $52.32 15
2017 Q4 507,440 $28,980,000 +$3,484,247 $57.10 15
2017 Q3 445,538 $22,919,000 -$2,504,136 $51.40 14
2017 Q2 510,834 $22,376,000 -$93,022,615 $43.81 15
2017 Q1 2,868,956 $113,770,000 +$7,010,708 $39.66 13
2016 Q4 2,697,842 $93,105,000 -$16,158,434 $34.51 12
2016 Q3 3,164,299 $140,338,000 +$125,356,100 $44.19 12
2016 Q2 336,708 $16,120,000 +$1,242,169 $47.73 12
2016 Q1 310,783 $13,969,000 +$3,361,613 $44.86 11
2015 Q4 235,681 $11,275,000 +$6,148,795 $47.75 11
2015 Q3 106,844 $4,644,000 -$5,312,449 $43.35 9
2015 Q2 218,188 $10,363,000 -$89,420,696 $47.50 10
2015 Q1 2,176,998 $99,514,000 +$93,468,549 $45.67 11
2014 Q4 132,833 $5,600,000 +$76,711 $42.17 9
2014 Q3 130,991 $5,668,000 -$72,801,234 $43.38 8
2014 Q2 1,579,788 $79,362,000 +$25,301,248 $50.24 10
2014 Q1 1,086,339 $47,774,000 -$3,689,114 $43.98 10